Fatal acute hepatitis C virus infection in patients with hematological malignancies

Journal of Chemotherapy

Volumn 18, Issue 6, 2006, Pages 662-664

  Taliani, Gloria ^a,c   Tozzi, A ^b   Fanci, R ^b   Biliotti, E ^a   Bosi, A ^b  

^a POLICLINICO UMBERTO I   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acute HCV infection; Fatal outcome; Hematologic malignancy; Immunocompromised patients; Liver failure

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; CYTARABINE; FLUDARABINE; HEPATITIS C ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANTIBIOTIC THERAPY; ANTIBODY TITER; ARTICLE; BLOOD CELL COUNT; BLOOD CULTURE; CASE REPORT; CLINICAL FEATURE; ENTEROBACTER CLOACAE; FATALITY; FEMALE; HEMATOLOGIC DISEASE; HEPATITIS C; HUMAN; IMMUNOCOMPROMISED PATIENT; LIVER FAILURE; LIVER FUNCTION TEST; NEUTROPENIA; RISK FACTOR; SEPSIS; SEROCONVERSION; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; URINE CULTURE;

EID: 33845998537     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2006.18.6.662     Document Type: Article

References (9)

1. Allander T, Gruber A, Naghavi M, et al. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet. 1995; 345: 603-607.
2. Silini E, Locasciull Ai, Santoleri L, et al. Hepatitis C virus infection in a hematology ward: evidence for nosocomial transmission and impact on hematologic disease outcome. Haematologica. 2002; 87: 1200-1208.
3. Zuckerman E, Zuckerman T, Douer D, et al. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies. Cancer 1998; 83: 1224-1230.
4. Vento S, Cainelli F, Mirandola F, et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 1996; 346: 92-93.
5. Gruber A, Norder H, Magnius L, et al. Late seroconversion and high chronicity rate of hepatitis C virus infection in patients with hematologic disorders. Ann Oncol. 1993; 4: 229-234.
6. Collier J, Heathcote J. Hepatitis C viral infection in the immunosuppressed patient. Hepatology. 1998; 27: 2-6.
7. EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement. J Hepatol. 1999; 31 Suppl 1: 3-8.
8. Strassburg CP. Gastrointestinal disorders of the critically ill. Shock liver. Best Pract Res Clin Gastroenterol. 2003; 17: 369-381.
9. Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 1995; 274: 968-974.